Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

A 204

Known as: A-204, antibiotic A 204 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Soft tissue sarcomas (STS) are a heterogeneous group of malignant tumours representing 1% of all malignancies in adults. Therapy… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2006
2006
Effectiveness of conventional cytotoxic treatment of rhabdomyosarcoma (RMS) may be limited by the development of multidrug… Expand
Highly Cited
2004
Highly Cited
2004
BackgroundSarcomas are one of the most refractory diseases among malignant tumors. More effective therapies based on an increased… Expand
2004
2004
Soft-tissue sarcomas are mesenchymal tumors that respond poorly to systemic chemotherapy. Suicide gene therapy may be an… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
2003
2003
Paediatric solid tumours exhibit steep dose-response curves to alkylating agents and are therefore considered candidates for high… Expand
1997
1997
We investigated a wild-type (wt) p53 rhabdomyosarcoma (A-204) and a mutated (mt p53) undifferentiated sarcoma cell line (US8-93… Expand
1994
1994
Abstract Studies directed toward the formation of methyl ethers in key intermediates for the synthesis of lonomycin A are… Expand
1989
1989
ABSTRACT: The presence of neonatal (cord) lymphokineactivated killer (LAK) cell activity toward natural killer cell resistant… Expand
  • figure 1
  • figure 2
  • figure 3
1987
1987
The antitumor activity and lethal toxicity of three acylated derivatives of chemically synthesized 4-Ο-monophosphorylglucosamine… Expand
1973
1973
Abstract Preliminary studies indicate that screening for anticoccidial activity is feasible in a cell culture system. Ten… Expand